• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Temple Grandin Genome: Comprehensive Analysis in a Scientist with High-Functioning Autism.天宝·格兰丁基因组:对一名患有高功能自闭症的科学家的综合分析。
J Pers Med. 2020 Dec 29;11(1):21. doi: 10.3390/jpm11010021.
2
Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.全外显子组测序鉴定出与自闭症谱系障碍中六个基因网络相互作用的新型新生变异。
Genes (Basel). 2020 Dec 22;12(1):1. doi: 10.3390/genes12010001.
3
Whole-Exome Sequencing Identifies Three Candidate Homozygous Variants in a Consanguineous Iranian Family with Autism Spectrum Disorder and Skeletal Problems.全外显子组测序在一个患有自闭症谱系障碍和骨骼问题的伊朗近亲家庭中鉴定出三个候选纯合变异体。
Mol Syndromol. 2020 Jun;11(2):62-72. doi: 10.1159/000506530. Epub 2020 Mar 11.
4
The genetics of autism.自闭症的遗传学
Pediatrics. 2004 May;113(5):e472-86. doi: 10.1542/peds.113.5.e472.
5
Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: Findings and implications.在患有自闭症谱系障碍的不同临床儿童群体中进行包括靶向基因panel在内的基因检测:研究结果与启示。
Mol Genet Genomic Med. 2018 Mar;6(2):171-185. doi: 10.1002/mgg3.354. Epub 2017 Dec 21.
6
Contribution of Multiple Inherited Variants to Autism Spectrum Disorder (ASD) in a Family with 3 Affected Siblings.家族中 3 名受影响的兄弟姐妹的自闭症谱系障碍 (ASD) 中多种遗传变异的贡献。
Genes (Basel). 2021 Jul 8;12(7):1053. doi: 10.3390/genes12071053.
7
Dendritic Spine in Autism Genetics: Whole-Exome Sequencing Identifying De Novo Variant of in a Quad Family Affected by Autism Spectrum Disorder.自闭症遗传学中的树突棘:全外显子组测序在一个受自闭症谱系障碍影响的四口之家中鉴定出从头变异。
Children (Basel). 2022 Dec 30;10(1):80. doi: 10.3390/children10010080.
8
Discovery and Validation of Novel Genes in a Large Chinese Autism Spectrum Disorder Cohort.在中国一个大型自闭症谱系障碍队列中新型基因的发现与验证
Biol Psychiatry. 2023 Nov 15;94(10):792-803. doi: 10.1016/j.biopsych.2023.06.025. Epub 2023 Jun 29.
9
Molecular investigation, using chromosomal microarray and whole exome sequencing, of six patients affected by Williams Beuren syndrome and Autism Spectrum Disorder.使用染色体微阵列和全外显子组测序对六名患有威廉姆斯-贝伦综合征和自闭症谱系障碍的患者进行分子研究。
Orphanet J Rare Dis. 2019 May 31;14(1):121. doi: 10.1186/s13023-019-1094-5.
10
Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.比较分子诊断算法在印度孤独症谱系障碍诊断中的效能:支持全外显子组测序作为一线检测的证据。
BMC Neurol. 2023 Aug 5;23(1):292. doi: 10.1186/s12883-023-03341-0.

引用本文的文献

1
Autism patient-derived SHANK2B mutation affects the development of ALDH1A1 negative dopamine neuron.自闭症患者来源的 SHANK2B 突变影响 ALDH1A1 阴性多巴胺神经元的发育。
Mol Psychiatry. 2024 Oct;29(10):3180-3194. doi: 10.1038/s41380-024-02578-6. Epub 2024 May 4.
2
Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics.线粒体靶向药物治疗自闭症谱系障碍:神经疾病治疗的未来。
Curr Neuropharmacol. 2023;21(5):1042-1064. doi: 10.2174/1570159X21666221121095618.
3
Monoallelic and biallelic mutations in RELN underlie a graded series of neurodevelopmental disorders.RELN 中的单等位基因和双等位基因突变导致了一系列程度不同的神经发育障碍。
Brain. 2022 Sep 14;145(9):3274-3287. doi: 10.1093/brain/awac164.
4
Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice?注意缺陷多动障碍(ADHD)诊所中的遗传学:基因检测如何支持当前的临床实践?
Front Psychol. 2022 Mar 8;13:751041. doi: 10.3389/fpsyg.2022.751041. eCollection 2022.
5
A Personalized Approach to Evaluating and Treating Autism Spectrum Disorder.一种评估和治疗自闭症谱系障碍的个性化方法。
J Pers Med. 2022 Jan 24;12(2):147. doi: 10.3390/jpm12020147.

本文引用的文献

1
From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer.从多基因风险评分的基础科学到临床应用:入门指南。
JAMA Psychiatry. 2021 Jan 1;78(1):101-109. doi: 10.1001/jamapsychiatry.2020.3049.
2
A clinically validated whole genome pipeline for structural variant detection and analysis.临床验证的全基因组结构变异检测和分析管道。
BMC Genomics. 2019 Jul 16;20(Suppl 8):545. doi: 10.1186/s12864-019-5866-z.
3
Identification of common genetic risk variants for autism spectrum disorder.孤独症谱系障碍常见遗传风险变异的鉴定。
Nat Genet. 2019 Mar;51(3):431-444. doi: 10.1038/s41588-019-0344-8. Epub 2019 Feb 25.
4
Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.自闭症/发育迟缓风险基因的遗传和新发突变提示了一种多因素模型。
Mol Autism. 2018 Dec 13;9:64. doi: 10.1186/s13229-018-0247-z. eCollection 2018.
5
ClinVar: improving access to variant interpretations and supporting evidence.ClinVar:改善变异解读和支持证据的获取。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. doi: 10.1093/nar/gkx1153.
6
Whole-Exome Sequencing Identifies Novel Variants for Tooth Agenesis.全外显子组测序鉴定出牙齿发育不全的新变异体。
J Dent Res. 2018 Jan;97(1):49-59. doi: 10.1177/0022034517724149. Epub 2017 Aug 16.
7
Analytical and Clinical Validity Study of FirstStepDx PLUS: A Chromosomal Microarray Optimized for Patients with Neurodevelopmental Conditions.FirstStepDx PLUS的分析与临床有效性研究:一种针对神经发育障碍患者优化的染色体微阵列检测技术
PLoS Curr. 2017 Feb 27;9:ecurrents.eogt.7d92ce775800ef3fbc72e3840fb1bc22. doi: 10.1371/currents.eogt.7d92ce775800ef3fbc72e3840fb1bc22.
8
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.临床药物基因组学实施联盟(CPIC)华法林给药的药物基因组学指导原则:2017年更新版
Clin Pharmacol Ther. 2017 Sep;102(3):397-404. doi: 10.1002/cpt.668. Epub 2017 Apr 4.
9
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.靶向测序鉴定出91个具有自闭症和发育障碍倾向的神经发育障碍风险基因。
Nat Genet. 2017 Apr;49(4):515-526. doi: 10.1038/ng.3792. Epub 2017 Feb 13.
10
Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.使用针对神经发育障碍优化的超高分辨率染色体微阵列对连续的自闭症谱系障碍个体进行染色体微阵列分析。
Int J Mol Sci. 2016 Dec 9;17(12):2070. doi: 10.3390/ijms17122070.

天宝·格兰丁基因组:对一名患有高功能自闭症的科学家的综合分析。

The Temple Grandin Genome: Comprehensive Analysis in a Scientist with High-Functioning Autism.

作者信息

Vanzo Rena J, Prasad Aparna, Staunch Lauren, Hensel Charles H, Serrano Moises A, Wassman E Robert, Kaplun Alexander, Grandin Temple, Boles Richard G

机构信息

Lineagen, Inc., Salt Lake City, UT 84109, USA.

Variantyx, Inc., Framingham, MA 01701, USA.

出版信息

J Pers Med. 2020 Dec 29;11(1):21. doi: 10.3390/jpm11010021.

DOI:10.3390/jpm11010021
PMID:33383702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7824360/
Abstract

Autism spectrum disorder (ASD) is a heterogeneous condition with a complex genetic etiology. The objective of this study is to identify the complex genetic factors that underlie the ASD phenotype and other clinical features of Professor Temple Grandin, an animal scientist and woman with high-functioning ASD. Identifying the underlying genetic cause for ASD can impact medical management, personalize services and treatment, and uncover other medical risks that are associated with the genetic diagnosis. Prof. Grandin underwent chromosomal microarray analysis, whole exome sequencing, and whole genome sequencing, as well as a comprehensive clinical and family history intake. The raw data were analyzed in order to identify possible genotype-phenotype correlations. Genetic testing identified variants in three genes (, , and ) that are candidate risk factors for ASD. We identified variants in and , reported to be disease-associated in previous studies, which are likely to contribute to some of her additional clinical features. Moreover, candidate variants in genes encoding metabolic enzymes and transporters were identified, some of which suggest potential therapies. This case report describes the genomic findings in Prof. Grandin and it serves as an example to discuss state-of-the-art clinical diagnostics for individuals with ASD, as well as the medical, logistical, and economic hurdles that are involved in clinical genetic testing for an individual on the autism spectrum.

摘要

自闭症谱系障碍(ASD)是一种具有复杂遗传病因的异质性疾病。本研究的目的是确定动物科学家、患有高功能ASD的坦普尔·格兰丁教授的ASD表型及其他临床特征背后的复杂遗传因素。确定ASD的潜在遗传原因可影响医疗管理、使服务和治疗个性化,并揭示与基因诊断相关的其他医疗风险。格兰丁教授接受了染色体微阵列分析、全外显子组测序和全基因组测序,以及全面的临床和家族病史采集。对原始数据进行分析以确定可能的基因型-表型相关性。基因检测确定了三个基因(、和)中的变异,这些变异是ASD的候选风险因素。我们在和中发现了变异,先前研究报道这些变异与疾病相关,它们可能导致了她的一些其他临床特征。此外,还确定了编码代谢酶和转运蛋白的基因中的候选变异,其中一些提示了潜在的治疗方法。本病例报告描述了格兰丁教授的基因组学发现,并作为一个例子来讨论针对ASD个体的最新临床诊断,以及自闭症谱系个体临床基因检测中涉及的医疗、后勤和经济障碍。